

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 7.90691400 |
| 2 | metanephric mesenchyme development (GO:0072075) | 7.25069498 |
| 3 | histone H2A monoubiquitination (GO:0035518) | 7.11294268 |
| 4 | metanephric nephron tubule development (GO:0072234) | 7.00425803 |
| 5 | metanephric tubule development (GO:0072170) | 7.00425803 |
| 6 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 6.91035917 |
| 7 | artery development (GO:0060840) | 6.71849582 |
| 8 | activin receptor signaling pathway (GO:0032924) | 6.40831489 |
| 9 | kidney mesenchyme development (GO:0072074) | 6.32726096 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 6.28148144 |
| 11 | metanephric nephron epithelium development (GO:0072243) | 6.27798316 |
| 12 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 6.21872197 |
| 13 | pyrimidine dimer repair (GO:0006290) | 6.14710740 |
| 14 | histone H2A ubiquitination (GO:0033522) | 6.06058681 |
| 15 | positive regulation of tolerance induction (GO:0002645) | 6.03413682 |
| 16 | thrombin receptor signaling pathway (GO:0070493) | 5.96019989 |
| 17 | positive regulation of mast cell activation (GO:0033005) | 5.94650114 |
| 18 | positive regulation of mast cell degranulation (GO:0043306) | 5.89440378 |
| 19 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 5.89440378 |
| 20 | metanephric epithelium development (GO:0072207) | 5.75870875 |
| 21 | cellular response to fluid shear stress (GO:0071498) | 5.32346621 |
| 22 | pre-miRNA processing (GO:0031054) | 5.22108631 |
| 23 | lipoxygenase pathway (GO:0019372) | 5.18537453 |
| 24 | regulation of tolerance induction (GO:0002643) | 5.17582595 |
| 25 | blood vessel maturation (GO:0001955) | 5.10060883 |
| 26 | neuromuscular process controlling posture (GO:0050884) | 5.05214281 |
| 27 | ovulation from ovarian follicle (GO:0001542) | 4.81164947 |
| 28 | response to water (GO:0009415) | 4.81161348 |
| 29 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.80281968 |
| 30 | definitive hemopoiesis (GO:0060216) | 4.75693475 |
| 31 | osteoclast differentiation (GO:0030316) | 4.74288268 |
| 32 | regulation of mast cell degranulation (GO:0043304) | 4.72915003 |
| 33 | megakaryocyte development (GO:0035855) | 4.70926736 |
| 34 | protein neddylation (GO:0045116) | 4.64405040 |
| 35 | smooth muscle tissue development (GO:0048745) | 4.52952627 |
| 36 | positive regulation of male gonad development (GO:2000020) | 4.49190403 |
| 37 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.45388202 |
| 38 | adenosine receptor signaling pathway (GO:0001973) | 4.44108000 |
| 39 | regulation of female receptivity (GO:0045924) | 4.40297618 |
| 40 | polarized epithelial cell differentiation (GO:0030859) | 4.39564848 |
| 41 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 4.33033560 |
| 42 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 4.33033560 |
| 43 | regulation of translation, ncRNA-mediated (GO:0045974) | 4.33033560 |
| 44 | regulation of platelet activation (GO:0010543) | 4.28011752 |
| 45 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 4.27479184 |
| 46 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.27088607 |
| 47 | establishment of apical/basal cell polarity (GO:0035089) | 4.24858352 |
| 48 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 4.23675437 |
| 49 | establishment of monopolar cell polarity (GO:0061162) | 4.23675437 |
| 50 | nephron tubule development (GO:0072080) | 4.21194023 |
| 51 | regulation of mast cell activation (GO:0033003) | 4.17163059 |
| 52 | spinal cord development (GO:0021510) | 4.11679475 |
| 53 | female mating behavior (GO:0060180) | 4.11272911 |
| 54 | regulation of platelet aggregation (GO:0090330) | 4.02988969 |
| 55 | regulation of male gonad development (GO:2000018) | 4.02057024 |
| 56 | glucosamine-containing compound catabolic process (GO:1901072) | 4.01204463 |
| 57 | imidazole-containing compound metabolic process (GO:0052803) | 3.98772550 |
| 58 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.93815952 |
| 59 | positive regulation of leukocyte degranulation (GO:0043302) | 3.92055571 |
| 60 | negative regulation of interleukin-12 production (GO:0032695) | 3.92007653 |
| 61 | neutrophil activation (GO:0042119) | 3.90112113 |
| 62 | negative regulation of bone resorption (GO:0045779) | 3.89485310 |
| 63 | aggressive behavior (GO:0002118) | 3.88855758 |
| 64 | membrane tubulation (GO:0097320) | 3.86097277 |
| 65 | renal tubule morphogenesis (GO:0061333) | 3.83403481 |
| 66 | positive regulation of amino acid transport (GO:0051957) | 3.82930908 |
| 67 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.79639934 |
| 68 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.79639934 |
| 69 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.77200541 |
| 70 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.77200541 |
| 71 | endothelium development (GO:0003158) | 3.73795600 |
| 72 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.72786180 |
| 73 | purinergic receptor signaling pathway (GO:0035587) | 3.71230657 |
| 74 | response to pheromone (GO:0019236) | 3.71008845 |
| 75 | centrosome duplication (GO:0051298) | 3.70103109 |
| 76 | angiogenesis involved in wound healing (GO:0060055) | 3.69022763 |
| 77 | renal tubule development (GO:0061326) | 3.64454070 |
| 78 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.63999331 |
| 79 | prepulse inhibition (GO:0060134) | 3.63700506 |
| 80 | cellular biogenic amine biosynthetic process (GO:0042401) | 3.60951082 |
| 81 | negative regulation of phagocytosis (GO:0050765) | 3.58196083 |
| 82 | regulation of integrin activation (GO:0033623) | 3.57521569 |
| 83 | striatum development (GO:0021756) | 3.55653832 |
| 84 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.55219008 |
| 85 | positive regulation of urine volume (GO:0035810) | 3.54923811 |
| 86 | positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737) | 3.54297703 |
| 87 | blood coagulation, intrinsic pathway (GO:0007597) | 3.53101466 |
| 88 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.51807334 |
| 89 | granulocyte activation (GO:0036230) | 3.50538706 |
| 90 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.49485832 |
| 91 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.49258095 |
| 92 | translesion synthesis (GO:0019985) | 3.48646516 |
| 93 | positive regulation of B cell differentiation (GO:0045579) | 3.48426670 |
| 94 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.47858226 |
| 95 | maturation of SSU-rRNA (GO:0030490) | 3.47214332 |
| 96 | regulation of leukocyte degranulation (GO:0043300) | 3.46995997 |
| 97 | neural tube development (GO:0021915) | 3.45972532 |
| 98 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.45830267 |
| 99 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.45830267 |
| 100 | negative regulation of cation channel activity (GO:2001258) | 3.43699605 |
| 101 | amine biosynthetic process (GO:0009309) | 3.43385063 |
| 102 | ear development (GO:0043583) | 3.43104827 |
| 103 | interleukin-1-mediated signaling pathway (GO:0070498) | 3.42266037 |
| 104 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.42260681 |
| 105 | ribosomal small subunit assembly (GO:0000028) | 3.41543492 |
| 106 | cellular response to osmotic stress (GO:0071470) | 3.41051324 |
| 107 | immunoglobulin mediated immune response (GO:0016064) | 3.40894868 |
| 108 | nephron epithelium development (GO:0072009) | 3.40188056 |
| 109 | regulation of T cell cytokine production (GO:0002724) | 3.35513516 |
| 110 | histone monoubiquitination (GO:0010390) | 3.33264067 |
| 111 | respiratory system process (GO:0003016) | 3.30668722 |
| 112 | inner ear receptor cell development (GO:0060119) | 3.29959685 |
| 113 | platelet aggregation (GO:0070527) | 3.29773744 |
| 114 | B cell mediated immunity (GO:0019724) | 3.27110341 |
| 115 | retinal rod cell development (GO:0046548) | 3.26334757 |
| 116 | male sex determination (GO:0030238) | 3.25817530 |
| 117 | monoamine transport (GO:0015844) | 3.24085058 |
| 118 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.22825056 |
| 119 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.21140628 |
| 120 | response to caffeine (GO:0031000) | 3.20960919 |
| 121 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.19764835 |
| 122 | negative regulation of bone remodeling (GO:0046851) | 3.18365419 |
| 123 | low-density lipoprotein particle remodeling (GO:0034374) | 3.17294971 |
| 124 | autophagic vacuole fusion (GO:0000046) | 3.15903221 |
| 125 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.11607806 |
| 126 | protein K6-linked ubiquitination (GO:0085020) | 3.11051209 |
| 127 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.06733570 |
| 128 | positive regulation of granulocyte differentiation (GO:0030854) | 3.05377456 |
| 129 | leukotriene biosynthetic process (GO:0019370) | 3.05015544 |
| 130 | purine-containing compound salvage (GO:0043101) | 3.04910586 |
| 131 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.04718102 |
| 132 | paraxial mesoderm development (GO:0048339) | 3.03762460 |
| 133 | muscle organ morphogenesis (GO:0048644) | 3.01853823 |
| 134 | cardiolipin metabolic process (GO:0032048) | 3.01685637 |
| 135 | icosanoid biosynthetic process (GO:0046456) | 3.01580199 |
| 136 | fatty acid derivative biosynthetic process (GO:1901570) | 3.01580199 |
| 137 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.00366641 |
| 138 | positive regulation of macrophage differentiation (GO:0045651) | 2.96767314 |
| 139 | negative regulation of T cell apoptotic process (GO:0070233) | 2.96736601 |
| 140 | cerebellar Purkinje cell layer development (GO:0021680) | 2.95758059 |
| 141 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.95651642 |
| 142 | determination of left/right symmetry (GO:0007368) | 2.95209274 |
| 143 | regulation of norepinephrine secretion (GO:0014061) | 2.94711950 |
| 144 | negative regulation of norepinephrine secretion (GO:0010700) | 2.94129097 |
| 145 | basic amino acid transport (GO:0015802) | 2.93859598 |
| 146 | organelle membrane fusion (GO:0090174) | 2.92818659 |
| 147 | leukocyte degranulation (GO:0043299) | 2.91680766 |
| 148 | regulation of macrophage cytokine production (GO:0010935) | 2.90302952 |
| 149 | embryonic placenta development (GO:0001892) | 2.89938914 |
| 150 | grooming behavior (GO:0007625) | 2.89774138 |
| 151 | RNA destabilization (GO:0050779) | 2.89663338 |
| 152 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.87921565 |
| 153 | negative regulation of heart rate (GO:0010459) | 2.87778527 |
| 154 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.86690081 |
| 155 | mature B cell differentiation involved in immune response (GO:0002313) | 2.86423747 |
| 156 | positive regulation of regulated secretory pathway (GO:1903307) | 2.83863580 |
| 157 | microglial cell activation (GO:0001774) | 2.83820693 |
| 158 | myeloid cell activation involved in immune response (GO:0002275) | 2.83554903 |
| 159 | regulation of penile erection (GO:0060405) | 2.82383411 |
| 160 | regulation of erythrocyte differentiation (GO:0045646) | 2.82311970 |
| 161 | regulation of glutamate secretion (GO:0014048) | 2.80787246 |
| 162 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.80655762 |
| 163 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.80126413 |
| 164 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.80126413 |
| 165 | determination of bilateral symmetry (GO:0009855) | 2.79948016 |
| 166 | synaptic transmission, dopaminergic (GO:0001963) | 2.79767707 |
| 167 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.78399949 |
| 168 | specification of symmetry (GO:0009799) | 2.77053559 |
| 169 | histone ubiquitination (GO:0016574) | 2.76643532 |
| 170 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.76462147 |
| 171 | leukotriene metabolic process (GO:0006691) | 2.74284363 |
| 172 | sleep (GO:0030431) | 2.71712695 |
| 173 | regulation of hypersensitivity (GO:0002883) | 2.70344439 |
| 174 | negative regulation of platelet activation (GO:0010544) | 2.69838606 |
| 175 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.66896790 |
| 176 | cellular response to exogenous dsRNA (GO:0071360) | 2.65691562 |
| 177 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.64818489 |
| 178 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.63456486 |
| 179 | regulation of regulated secretory pathway (GO:1903305) | 2.60968545 |
| 180 | defense response to protozoan (GO:0042832) | 2.59106842 |
| 181 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.58325837 |
| 182 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.58069293 |
| 183 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.57800256 |
| 184 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.57785298 |
| 185 | regulation of cholesterol efflux (GO:0010874) | 2.55940945 |
| 186 | cellular biogenic amine catabolic process (GO:0042402) | 2.55827795 |
| 187 | amine catabolic process (GO:0009310) | 2.55827795 |
| 188 | mitochondrial calcium ion transport (GO:0006851) | 2.55164687 |
| 189 | mast cell activation (GO:0045576) | 2.53965470 |
| 190 | regulation of megakaryocyte differentiation (GO:0045652) | 2.52248492 |
| 191 | polyamine biosynthetic process (GO:0006596) | 2.51013985 |
| 192 | platelet degranulation (GO:0002576) | 2.50041301 |
| 193 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.49727720 |
| 194 | regulation of activated T cell proliferation (GO:0046006) | 2.49467247 |
| 195 | platelet activation (GO:0030168) | 2.48644395 |
| 196 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.48395611 |
| 197 | nodal signaling pathway (GO:0038092) | 14.0064241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.52551936 |
| 2 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.67089750 |
| 3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.50845881 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.40145405 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.27150540 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.26284897 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.20888788 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.18132780 |
| 9 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 3.16716174 |
| 10 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.95178017 |
| 11 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.82090249 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.77960088 |
| 13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.74319016 |
| 14 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.71687220 |
| 15 | GATA1_19941826_ChIP-Seq_K562_Human | 2.69820772 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.68587663 |
| 17 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.65199426 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.64020803 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.60251219 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.47461559 |
| 21 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 2.47171239 |
| 22 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.44906455 |
| 23 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.35431263 |
| 24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.34558878 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.32331089 |
| 26 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.29649692 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.29185282 |
| 28 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.27461805 |
| 29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.27461805 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.27320544 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23464547 |
| 32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.22917448 |
| 33 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.20453101 |
| 34 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.16651830 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 2.15476882 |
| 36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.13384491 |
| 37 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.12583411 |
| 38 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.11711797 |
| 39 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.10485690 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10182544 |
| 41 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.07924553 |
| 42 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.03126706 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.00681422 |
| 44 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00302253 |
| 45 | GATA2_19941826_ChIP-Seq_K562_Human | 2.00282669 |
| 46 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.97467843 |
| 47 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.96830105 |
| 48 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.94020767 |
| 49 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.94008732 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93327869 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.92271333 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.90409120 |
| 53 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.89527239 |
| 54 | MYB_26560356_Chip-Seq_TH2_Human | 1.88136113 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.86737078 |
| 56 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.85512355 |
| 57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.84651677 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.83312719 |
| 59 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.79763344 |
| 60 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78438413 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78358802 |
| 62 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.75931692 |
| 63 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73205227 |
| 64 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.71954347 |
| 65 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.70267652 |
| 66 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.68020130 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.63444490 |
| 68 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.62683756 |
| 69 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.61939049 |
| 70 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.60828522 |
| 71 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.54870046 |
| 72 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51333989 |
| 73 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.51167048 |
| 74 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49196129 |
| 75 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48119266 |
| 76 | UTX_26944678_Chip-Seq_JUKART_Human | 1.46830021 |
| 77 | * SPI1_20517297_ChIP-Seq_HL60_Human | 1.44846690 |
| 78 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44722294 |
| 79 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.44112498 |
| 80 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.43447452 |
| 81 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.43099650 |
| 82 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.41265012 |
| 83 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40953810 |
| 84 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.40015914 |
| 85 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.39324614 |
| 86 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.37570051 |
| 87 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.36556074 |
| 88 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.36272967 |
| 89 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36167301 |
| 90 | MYC_22102868_ChIP-Seq_BL_Human | 1.35887691 |
| 91 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.34641329 |
| 92 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32233850 |
| 93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.30945333 |
| 94 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30603950 |
| 95 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.30177143 |
| 96 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.30078974 |
| 97 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.29439514 |
| 98 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.27862857 |
| 99 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.27706793 |
| 100 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.26975066 |
| 101 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.26671322 |
| 102 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.26591069 |
| 103 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26183330 |
| 104 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.24523411 |
| 105 | P300_27268052_Chip-Seq_Bcells_Human | 1.22998133 |
| 106 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.21146513 |
| 107 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.19893412 |
| 108 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17708213 |
| 109 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.16738730 |
| 110 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.16494382 |
| 111 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.15469308 |
| 112 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15278753 |
| 113 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.15124338 |
| 114 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.14462234 |
| 115 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.14402506 |
| 116 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.13542671 |
| 117 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13542671 |
| 118 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13501349 |
| 119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.13490329 |
| 120 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.13340493 |
| 121 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.13202991 |
| 122 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11806508 |
| 123 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11021323 |
| 124 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10540154 |
| 125 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.10290891 |
| 126 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09010137 |
| 127 | P300_19829295_ChIP-Seq_ESCs_Human | 1.08227180 |
| 128 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.08046198 |
| 129 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.08036937 |
| 130 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07007931 |
| 131 | TP53_16413492_ChIP-PET_HCT116_Human | 1.04782075 |
| 132 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.04750560 |
| 133 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.03701017 |
| 134 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03460338 |
| 135 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.01962554 |
| 136 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.01880898 |
| 137 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.00948184 |
| 138 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.00784287 |
| 139 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00595913 |
| 140 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.99536060 |
| 141 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98735774 |
| 142 | MYB_26560356_Chip-Seq_TH1_Human | 0.98491637 |
| 143 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.98349981 |
| 144 | FUS_26573619_Chip-Seq_HEK293_Human | 0.98199359 |
| 145 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.98037651 |
| 146 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.97748067 |
| 147 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.97508594 |
| 148 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96804107 |
| 149 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.96634560 |
| 150 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96572912 |
| 151 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.96246076 |
| 152 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95549236 |
| 153 | MAF_26560356_Chip-Seq_TH1_Human | 0.95218437 |
| 154 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.95216274 |
| 155 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94741401 |
| 156 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.94695526 |
| 157 | AR_20517297_ChIP-Seq_VCAP_Human | 0.94221071 |
| 158 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.94168617 |
| 159 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93763180 |
| 160 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93191070 |
| 161 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92595421 |
| 162 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.92304593 |
| 163 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.91054678 |
| 164 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90626309 |
| 165 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.90572340 |
| 166 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.89939336 |
| 167 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.89918851 |
| 168 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89706385 |
| 169 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.88189388 |
| 170 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.86838405 |
| 171 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86118815 |
| 172 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.85906583 |
| 173 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.85615172 |
| 174 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85463936 |
| 175 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85026879 |
| 176 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.84765216 |
| 177 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84504718 |
| 178 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.83887768 |
| 179 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.83756905 |
| 180 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.82649041 |
| 181 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.81860435 |
| 182 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81217219 |
| 183 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.81079262 |
| 184 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.78742664 |
| 185 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.78405896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 7.03184744 |
| 2 | MP0004510_myositis | 6.51253899 |
| 3 | MP0004133_heterotaxia | 5.77245833 |
| 4 | MP0002254_reproductive_system_inflammat | 5.76887905 |
| 5 | MP0001851_eye_inflammation | 4.21090844 |
| 6 | MP0003724_increased_susceptibility_to | 4.17719812 |
| 7 | MP0001873_stomach_inflammation | 4.04857387 |
| 8 | MP0003941_abnormal_skin_development | 3.98733811 |
| 9 | MP0003303_peritoneal_inflammation | 3.71436013 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 3.24557239 |
| 11 | MP0008004_abnormal_stomach_pH | 3.12488605 |
| 12 | MP0003252_abnormal_bile_duct | 3.08763015 |
| 13 | MP0005397_hematopoietic_system_phenotyp | 3.03355485 |
| 14 | MP0001545_abnormal_hematopoietic_system | 3.03355485 |
| 15 | MP0005646_abnormal_pituitary_gland | 2.68018490 |
| 16 | MP0006082_CNS_inflammation | 2.52158901 |
| 17 | MP0009278_abnormal_bone_marrow | 2.47945092 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.46262429 |
| 19 | MP0005084_abnormal_gallbladder_morpholo | 2.39295504 |
| 20 | MP0001835_abnormal_antigen_presentation | 2.35835117 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 2.31820976 |
| 22 | MP0003436_decreased_susceptibility_to | 2.21197453 |
| 23 | MP0008877_abnormal_DNA_methylation | 2.08942805 |
| 24 | MP0002998_abnormal_bone_remodeling | 2.07315972 |
| 25 | MP0005000_abnormal_immune_tolerance | 2.01207531 |
| 26 | MP0003283_abnormal_digestive_organ | 10.5800530 |
| 27 | MP0005423_abnormal_somatic_nervous | 1.99855886 |
| 28 | MP0005671_abnormal_response_to | 1.89362428 |
| 29 | MP0001849_ear_inflammation | 1.83653457 |
| 30 | MP0002419_abnormal_innate_immunity | 1.81962852 |
| 31 | MP0010030_abnormal_orbit_morphology | 1.77583811 |
| 32 | MP0000230_abnormal_systemic_arterial | 1.74866060 |
| 33 | MP0002735_abnormal_chemical_nociception | 1.70793343 |
| 34 | MP0001340_abnormal_eyelid_morphology | 1.70768405 |
| 35 | MP0004859_abnormal_synaptic_plasticity | 1.65614240 |
| 36 | MP0004270_analgesia | 1.64840702 |
| 37 | MP0000343_altered_response_to | 1.64348260 |
| 38 | MP0008872_abnormal_physiological_respon | 1.61660514 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.60627050 |
| 40 | MP0002933_joint_inflammation | 1.59109335 |
| 41 | MP0002398_abnormal_bone_marrow | 1.58602764 |
| 42 | MP0005410_abnormal_fertilization | 1.57739283 |
| 43 | MP0005025_abnormal_response_to | 1.57710317 |
| 44 | MP0001800_abnormal_humoral_immune | 1.54126369 |
| 45 | MP0002420_abnormal_adaptive_immunity | 1.52549843 |
| 46 | MP0001819_abnormal_immune_cell | 1.52415423 |
| 47 | MP0009765_abnormal_xenobiotic_induced | 1.51612795 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.51286415 |
| 49 | MP0001790_abnormal_immune_system | 1.39980693 |
| 50 | MP0005387_immune_system_phenotype | 1.39980693 |
| 51 | MP0001986_abnormal_taste_sensitivity | 1.39961142 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.36941154 |
| 53 | MP0003172_abnormal_lysosome_physiology | 1.34747920 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.32974410 |
| 55 | MP0005083_abnormal_biliary_tract | 1.32003241 |
| 56 | MP0009763_increased_sensitivity_to | 1.30108878 |
| 57 | MP0005167_abnormal_blood-brain_barrier | 1.30098023 |
| 58 | MP0002429_abnormal_blood_cell | 1.24788949 |
| 59 | MP0000716_abnormal_immune_system | 1.23705837 |
| 60 | MP0003221_abnormal_cardiomyocyte_apopto | 1.23677536 |
| 61 | MP0002722_abnormal_immune_system | 1.23367118 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.23341981 |
| 63 | MP0003828_pulmonary_edema | 1.22297033 |
| 64 | MP0004147_increased_porphyrin_level | 1.22174488 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.21187669 |
| 66 | MP0003943_abnormal_hepatobiliary_system | 1.19360014 |
| 67 | MP0004885_abnormal_endolymph | 1.13437244 |
| 68 | MP0002405_respiratory_system_inflammati | 1.13197441 |
| 69 | MP0003635_abnormal_synaptic_transmissio | 1.10342169 |
| 70 | MP0005174_abnormal_tail_pigmentation | 1.09988085 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 1.09459523 |
| 72 | MP0002396_abnormal_hematopoietic_system | 1.07314088 |
| 73 | MP0005670_abnormal_white_adipose | 1.05171167 |
| 74 | MP0003950_abnormal_plasma_membrane | 1.01343339 |
| 75 | MP0003718_maternal_effect | 1.00864745 |
| 76 | MP0001663_abnormal_digestive_system | 1.00464716 |
| 77 | MP0005394_taste/olfaction_phenotype | 0.99021192 |
| 78 | MP0005499_abnormal_olfactory_system | 0.99021192 |
| 79 | MP0008775_abnormal_heart_ventricle | 0.98931905 |
| 80 | MP0009046_muscle_twitch | 0.98493865 |
| 81 | MP0002139_abnormal_hepatobiliary_system | 0.96900166 |
| 82 | MP0009785_altered_susceptibility_to | 0.96378531 |
| 83 | MP0002075_abnormal_coat/hair_pigmentati | 0.96048927 |
| 84 | MP0006036_abnormal_mitochondrial_physio | 0.95505063 |
| 85 | MP0008469_abnormal_protein_level | 0.94648111 |
| 86 | MP0003938_abnormal_ear_development | 0.94111767 |
| 87 | MP0005165_increased_susceptibility_to | 0.94087336 |
| 88 | MP0005220_abnormal_exocrine_pancreas | 0.92132651 |
| 89 | MP0000249_abnormal_blood_vessel | 0.90418852 |
| 90 | MP0009697_abnormal_copulation | 0.90394239 |
| 91 | MP0000049_abnormal_middle_ear | 0.90317836 |
| 92 | MP0005248_abnormal_Harderian_gland | 0.90001837 |
| 93 | MP0004947_skin_inflammation | 0.89984944 |
| 94 | MP0002063_abnormal_learning/memory/cond | 0.88042878 |
| 95 | MP0003183_abnormal_peptide_metabolism | 0.86698649 |
| 96 | MP0000685_abnormal_immune_system | 0.86078898 |
| 97 | MP0001186_pigmentation_phenotype | 0.85691400 |
| 98 | MP0008789_abnormal_olfactory_epithelium | 0.84629991 |
| 99 | MP0005390_skeleton_phenotype | 0.83039837 |
| 100 | MP0002822_catalepsy | 0.82605136 |
| 101 | MP0005381_digestive/alimentary_phenotyp | 0.82244896 |
| 102 | MP0001970_abnormal_pain_threshold | 0.81454037 |
| 103 | MP0005503_abnormal_tendon_morphology | 0.80690016 |
| 104 | MP0001664_abnormal_digestion | 0.80642280 |
| 105 | MP0008873_increased_physiological_sensi | 0.80506259 |
| 106 | MP0009333_abnormal_splenocyte_physiolog | 0.80440076 |
| 107 | MP0005075_abnormal_melanosome_morpholog | 0.79333605 |
| 108 | MP0009745_abnormal_behavioral_response | 0.79317703 |
| 109 | MP0010329_abnormal_lipoprotein_level | 0.79298045 |
| 110 | MP0008874_decreased_physiological_sensi | 0.78377962 |
| 111 | MP0003880_abnormal_central_pattern | 0.77898974 |
| 112 | MP0003385_abnormal_body_wall | 0.77723547 |
| 113 | MP0005666_abnormal_adipose_tissue | 0.76761707 |
| 114 | MP0001502_abnormal_circadian_rhythm | 0.75985666 |
| 115 | MP0004036_abnormal_muscle_relaxation | 0.75787357 |
| 116 | MP0003763_abnormal_thymus_physiology | 0.74630837 |
| 117 | MP0000465_gastrointestinal_hemorrhage | 0.74434265 |
| 118 | MP0003075_altered_response_to | 0.74184185 |
| 119 | MP0004084_abnormal_cardiac_muscle | 0.73902704 |
| 120 | MP0002064_seizures | 0.73219896 |
| 121 | * MP0009642_abnormal_blood_homeostasis | 0.73142201 |
| 122 | MP0009840_abnormal_foam_cell | 0.72975982 |
| 123 | MP0004883_abnormal_blood_vessel | 0.72650742 |
| 124 | MP0001944_abnormal_pancreas_morphology | 0.72476410 |
| 125 | MP0002249_abnormal_larynx_morphology | 0.71686102 |
| 126 | MP0001529_abnormal_vocalization | 0.70937280 |
| 127 | MP0004272_abnormal_basement_membrane | 0.70752972 |
| 128 | MP0001486_abnormal_startle_reflex | 0.70065017 |
| 129 | MP0004185_abnormal_adipocyte_glucose | 0.69705192 |
| 130 | MP0002877_abnormal_melanocyte_morpholog | 0.68329781 |
| 131 | * MP0002557_abnormal_social/conspecific_i | 0.67865507 |
| 132 | MP0000566_synostosis | 0.67431957 |
| 133 | MP0006072_abnormal_retinal_apoptosis | 0.66651365 |
| 134 | MP0003795_abnormal_bone_structure | 0.66355833 |
| 135 | MP0000703_abnormal_thymus_morphology | 0.65931268 |
| 136 | MP0003300_gastrointestinal_ulcer | 0.65770333 |
| 137 | MP0005448_abnormal_energy_balance | 0.65180560 |
| 138 | * MP0002233_abnormal_nose_morphology | 0.64680168 |
| 139 | MP0002019_abnormal_tumor_incidence | 0.64607613 |
| 140 | MP0008058_abnormal_DNA_repair | 0.64505088 |
| 141 | MP0002132_abnormal_respiratory_system | 0.63769734 |
| 142 | MP0002733_abnormal_thermal_nociception | 0.63344015 |
| 143 | MP0003115_abnormal_respiratory_system | 0.61980220 |
| 144 | MP0001501_abnormal_sleep_pattern | 0.58780747 |
| 145 | * MP0002572_abnormal_emotion/affect_behav | 0.58490743 |
| 146 | MP0000778_abnormal_nervous_system | 0.57932925 |
| 147 | MP0002113_abnormal_skeleton_development | 0.54811761 |
| 148 | MP0001968_abnormal_touch/_nociception | 0.54483442 |
| 149 | MP0000470_abnormal_stomach_morphology | 0.54357142 |
| 150 | MP0003866_abnormal_defecation | 0.53561061 |
| 151 | * MP0002184_abnormal_innervation | 0.53382587 |
| 152 | MP0006276_abnormal_autonomic_nervous | 0.52559160 |
| 153 | MP0000534_abnormal_ureter_morphology | 0.52244316 |
| 154 | MP0005085_abnormal_gallbladder_physiolo | 0.52223850 |
| 155 | MP0002083_premature_death | 0.52052895 |
| 156 | MP0008569_lethality_at_weaning | 0.52019021 |
| 157 | MP0003787_abnormal_imprinting | 0.50174125 |
| 158 | MP0002932_abnormal_joint_morphology | 0.49719707 |
| 159 | MP0005360_urolithiasis | 0.49449097 |
| 160 | MP0005164_abnormal_response_to | 0.47037450 |
| 161 | MP0003638_abnormal_response/metabolism_ | 0.47035204 |
| 162 | MP0002736_abnormal_nociception_after | 0.46548192 |
| 163 | MP0003879_abnormal_hair_cell | 0.46174369 |
| 164 | MP0005551_abnormal_eye_electrophysiolog | 0.44556446 |
| 165 | MP0000613_abnormal_salivary_gland | 0.44483161 |
| 166 | MP0002723_abnormal_immune_serum | 0.44370750 |
| 167 | MP0005501_abnormal_skin_physiology | 0.42027917 |
| 168 | * MP0002272_abnormal_nervous_system | 0.41202250 |
| 169 | MP0000955_abnormal_spinal_cord | 0.41172605 |
| 170 | MP0002090_abnormal_vision | 0.41068520 |
| 171 | MP0000689_abnormal_spleen_morphology | 0.40770224 |
| 172 | MP0004742_abnormal_vestibular_system | 0.40405811 |
| 173 | MP0001963_abnormal_hearing_physiology | 0.39847657 |
| 174 | MP0009764_decreased_sensitivity_to | 0.39833522 |
| 175 | MP0002067_abnormal_sensory_capabilities | 0.37753719 |
| 176 | MP0004085_abnormal_heartbeat | 0.36845566 |
| 177 | MP0000751_myopathy | 0.36704088 |
| 178 | MP0010386_abnormal_urinary_bladder | 0.35830293 |
| 179 | MP0005166_decreased_susceptibility_to | 0.35403533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 9.03845130 |
| 2 | Abdominal situs inversus (HP:0003363) | 8.35712786 |
| 3 | Abnormality of abdominal situs (HP:0011620) | 8.35712786 |
| 4 | Petechiae (HP:0000967) | 8.15982859 |
| 5 | Entropion (HP:0000621) | 7.92742790 |
| 6 | Poikiloderma (HP:0001029) | 7.36742627 |
| 7 | Purpura (HP:0000979) | 7.31609433 |
| 8 | Menorrhagia (HP:0000132) | 7.10828315 |
| 9 | Increased mean platelet volume (HP:0011877) | 7.05695746 |
| 10 | Abnormal platelet volume (HP:0011876) | 6.71273148 |
| 11 | Epistaxis (HP:0000421) | 6.31447671 |
| 12 | Striae distensae (HP:0001065) | 6.08290935 |
| 13 | Constricted visual fields (HP:0001133) | 5.08990438 |
| 14 | Abnormality of DNA repair (HP:0003254) | 5.08080949 |
| 15 | Limb hypertonia (HP:0002509) | 4.84771501 |
| 16 | Oligodontia (HP:0000677) | 4.75108760 |
| 17 | Abnormal ventriculo-arterial connection (HP:0011563) | 4.66030359 |
| 18 | Transposition of the great arteries (HP:0001669) | 4.66030359 |
| 19 | Abnormal connection of the cardiac segments (HP:0011545) | 4.66030359 |
| 20 | Stillbirth (HP:0003826) | 4.65577088 |
| 21 | Truncus arteriosus (HP:0001660) | 4.63331874 |
| 22 | Gingival bleeding (HP:0000225) | 4.59273141 |
| 23 | Abnormal sex determination (HP:0012244) | 4.51701359 |
| 24 | Sex reversal (HP:0012245) | 4.51701359 |
| 25 | True hermaphroditism (HP:0010459) | 4.32529015 |
| 26 | Abnormal platelet function (HP:0011869) | 4.15119004 |
| 27 | Impaired platelet aggregation (HP:0003540) | 4.15119004 |
| 28 | Failure to thrive in infancy (HP:0001531) | 4.06600141 |
| 29 | Ectropion (HP:0000656) | 3.96441198 |
| 30 | Chin dimple (HP:0010751) | 3.95637943 |
| 31 | Hyperlipoproteinemia (HP:0010980) | 3.94419393 |
| 32 | Spontaneous hematomas (HP:0007420) | 3.73264285 |
| 33 | Abnormality of the periventricular white matter (HP:0002518) | 3.49058931 |
| 34 | Stomatitis (HP:0010280) | 3.41972312 |
| 35 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.40540161 |
| 36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.39813757 |
| 37 | Dyschromatopsia (HP:0007641) | 3.39360499 |
| 38 | Late onset (HP:0003584) | 3.26287945 |
| 39 | Ankyloglossia (HP:0010296) | 3.23926230 |
| 40 | Hepatosplenomegaly (HP:0001433) | 3.21283899 |
| 41 | Abnormality of the prostate (HP:0008775) | 3.20992093 |
| 42 | Decreased central vision (HP:0007663) | 3.18682213 |
| 43 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.17465230 |
| 44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.16908052 |
| 45 | Male infertility (HP:0003251) | 3.16377437 |
| 46 | Dysostosis multiplex (HP:0000943) | 3.10743471 |
| 47 | Increased cerebral lipofuscin (HP:0011813) | 3.04537052 |
| 48 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.99662472 |
| 49 | Atrioventricular canal defect (HP:0006695) | 2.99147477 |
| 50 | Genetic anticipation (HP:0003743) | 2.85741985 |
| 51 | Childhood onset (HP:0011463) | 2.85059158 |
| 52 | Autoimmune thrombocytopenia (HP:0001973) | 2.84509254 |
| 53 | Chronic obstructive pulmonary disease (HP:0006510) | 2.84106379 |
| 54 | Obstructive lung disease (HP:0006536) | 2.84106379 |
| 55 | Progressive inability to walk (HP:0002505) | 2.83869819 |
| 56 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.83483798 |
| 57 | Abnormality of iron homeostasis (HP:0011031) | 2.76007522 |
| 58 | Abnormality of macrophages (HP:0004311) | 2.70151190 |
| 59 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.64553892 |
| 60 | Abnormal hair whorl (HP:0010721) | 2.63807464 |
| 61 | Conjunctival telangiectasia (HP:0000524) | 2.63548550 |
| 62 | Annular pancreas (HP:0001734) | 2.63073917 |
| 63 | Lack of skin elasticity (HP:0100679) | 2.63013444 |
| 64 | Pigmentary retinal degeneration (HP:0001146) | 2.60698052 |
| 65 | Flat cornea (HP:0007720) | 2.58193878 |
| 66 | Increased serum ferritin (HP:0003281) | 2.58185524 |
| 67 | Bruising susceptibility (HP:0000978) | 2.57457182 |
| 68 | Abnormality of lateral ventricle (HP:0030047) | 2.55146788 |
| 69 | Poikilocytosis (HP:0004447) | 2.54320736 |
| 70 | Thrombocytosis (HP:0001894) | 2.47469090 |
| 71 | Increased IgM level (HP:0003496) | 2.47343686 |
| 72 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.46670134 |
| 73 | Progressive cerebellar ataxia (HP:0002073) | 2.44086382 |
| 74 | Type 2 muscle fiber atrophy (HP:0003554) | 2.43354987 |
| 75 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.42588612 |
| 76 | Episodic fever (HP:0001954) | 2.41196940 |
| 77 | Intrahepatic cholestasis (HP:0001406) | 2.40287182 |
| 78 | Autoimmune hemolytic anemia (HP:0001890) | 2.38304369 |
| 79 | Muscle fiber atrophy (HP:0100295) | 2.37041776 |
| 80 | Abnormality of oral frenula (HP:0000190) | 2.36222603 |
| 81 | Attenuation of retinal blood vessels (HP:0007843) | 2.30708607 |
| 82 | Progressive microcephaly (HP:0000253) | 2.29942183 |
| 83 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.29817774 |
| 84 | Panhypogammaglobulinemia (HP:0003139) | 2.25608411 |
| 85 | Squamous cell carcinoma (HP:0002860) | 2.24632559 |
| 86 | Occipital encephalocele (HP:0002085) | 2.22602175 |
| 87 | Joint swelling (HP:0001386) | 2.14644485 |
| 88 | Acanthocytosis (HP:0001927) | 2.12682037 |
| 89 | Abnormality of methionine metabolism (HP:0010901) | 2.11816494 |
| 90 | Leukocytosis (HP:0001974) | 2.11483172 |
| 91 | Abnormality of B cell number (HP:0010975) | 2.09127016 |
| 92 | Keratitis (HP:0000491) | 2.09099887 |
| 93 | Visual hallucinations (HP:0002367) | 2.08913767 |
| 94 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.07677771 |
| 95 | Granulocytopenia (HP:0001913) | 2.06645804 |
| 96 | Vacuolated lymphocytes (HP:0001922) | 2.06428918 |
| 97 | Chest pain (HP:0100749) | 2.05635449 |
| 98 | Recurrent abscess formation (HP:0002722) | 2.05190410 |
| 99 | Thickened calvaria (HP:0002684) | 2.05055077 |
| 100 | Round face (HP:0000311) | 2.04683288 |
| 101 | Testicular neoplasm (HP:0010788) | 2.03774141 |
| 102 | Encephalitis (HP:0002383) | 2.02708977 |
| 103 | Basal ganglia calcification (HP:0002135) | 2.00392554 |
| 104 | Double outlet right ventricle (HP:0001719) | 10.2537595 |
| 105 | Congenital malformation of the right heart (HP:0011723) | 10.2537595 |
| 106 | Abnormal pancreas size (HP:0012094) | 1.99409467 |
| 107 | Abolished electroretinogram (ERG) (HP:0000550) | 1.97735839 |
| 108 | Arterial thrombosis (HP:0004420) | 1.94055496 |
| 109 | Paralysis (HP:0003470) | 1.93559002 |
| 110 | Vasculitis (HP:0002633) | 1.92081399 |
| 111 | Abnormality of the common coagulation pathway (HP:0010990) | 1.92027302 |
| 112 | Myositis (HP:0100614) | 1.91424452 |
| 113 | Hyperventilation (HP:0002883) | 1.90376386 |
| 114 | Abnormal pupillary function (HP:0007686) | 1.87023074 |
| 115 | Recurrent bacterial skin infections (HP:0005406) | 1.86139197 |
| 116 | Eosinophilia (HP:0001880) | 1.85193836 |
| 117 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.83531020 |
| 118 | Intellectual disability, profound (HP:0002187) | 1.82157960 |
| 119 | Slow saccadic eye movements (HP:0000514) | 1.81290847 |
| 120 | Myopathic facies (HP:0002058) | 1.80297652 |
| 121 | Meningitis (HP:0001287) | 1.79893446 |
| 122 | Neonatal hypoglycemia (HP:0001998) | 1.79389353 |
| 123 | Tubulointerstitial nephritis (HP:0001970) | 1.77942647 |
| 124 | Asymmetric septal hypertrophy (HP:0001670) | 1.77696534 |
| 125 | Vertigo (HP:0002321) | 1.76882819 |
| 126 | Mucopolysacchariduria (HP:0008155) | 1.75507955 |
| 127 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.75507955 |
| 128 | Weak cry (HP:0001612) | 1.74142799 |
| 129 | Pulmonary fibrosis (HP:0002206) | 1.73842035 |
| 130 | Pulmonary embolism (HP:0002204) | 1.73055995 |
| 131 | Agammaglobulinemia (HP:0004432) | 1.73007401 |
| 132 | Systemic lupus erythematosus (HP:0002725) | 1.72872932 |
| 133 | Hypothermia (HP:0002045) | 1.71365158 |
| 134 | Arterial tortuosity (HP:0005116) | 1.70577058 |
| 135 | Renal Fanconi syndrome (HP:0001994) | 1.70291234 |
| 136 | Poor speech (HP:0002465) | 1.69206091 |
| 137 | 3-Methylglutaconic aciduria (HP:0003535) | 1.68626129 |
| 138 | Recurrent fungal infections (HP:0002841) | 1.68150639 |
| 139 | Delayed myelination (HP:0012448) | 1.67974434 |
| 140 | Abnormality of the costochondral junction (HP:0000919) | 1.67668402 |
| 141 | Abnormality of eosinophils (HP:0001879) | 1.66095081 |
| 142 | Thrombophlebitis (HP:0004418) | 1.66037142 |
| 143 | Dysautonomia (HP:0002459) | 1.65905169 |
| 144 | Orchitis (HP:0100796) | 1.65821651 |
| 145 | Recurrent viral infections (HP:0004429) | 1.65682646 |
| 146 | Spondylolisthesis (HP:0003302) | 1.65097081 |
| 147 | Eczematoid dermatitis (HP:0000976) | 1.63043363 |
| 148 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.61543459 |
| 149 | Clonus (HP:0002169) | 1.60212039 |
| 150 | Generalized aminoaciduria (HP:0002909) | 1.58945454 |
| 151 | Postural tremor (HP:0002174) | 1.58891782 |
| 152 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.58807963 |
| 153 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.58807963 |
| 154 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.58807963 |
| 155 | Absent frontal sinuses (HP:0002688) | 1.58788137 |
| 156 | Febrile seizures (HP:0002373) | 1.58638168 |
| 157 | Chronic otitis media (HP:0000389) | 1.58608046 |
| 158 | Tinnitus (HP:0000360) | 1.57707625 |
| 159 | Gonadal dysgenesis (HP:0000133) | 1.57591053 |
| 160 | Bifid scrotum (HP:0000048) | 1.57090551 |
| 161 | Hyperthyroidism (HP:0000836) | 1.56893462 |
| 162 | Anhidrosis (HP:0000970) | 1.56020407 |
| 163 | Nausea (HP:0002018) | 1.55623856 |
| 164 | Fatigable weakness (HP:0003473) | 1.55290334 |
| 165 | Abnormality of the neuromuscular junction (HP:0003398) | 1.55290334 |
| 166 | Abnormality of the fingertips (HP:0001211) | 1.54815044 |
| 167 | Bifid uvula (HP:0000193) | 1.54586941 |
| 168 | Gowers sign (HP:0003391) | 1.53254710 |
| 169 | J-shaped sella turcica (HP:0002680) | 1.51995254 |
| 170 | Mask-like facies (HP:0000298) | 1.51980609 |
| 171 | Male pseudohermaphroditism (HP:0000037) | 1.51255906 |
| 172 | Optic neuritis (HP:0100653) | 1.49313679 |
| 173 | Retrobulbar optic neuritis (HP:0100654) | 1.49313679 |
| 174 | Hypophosphatemic rickets (HP:0004912) | 1.49300025 |
| 175 | Nonprogressive disorder (HP:0003680) | 1.48962529 |
| 176 | B lymphocytopenia (HP:0010976) | 1.48031806 |
| 177 | Progressive hearing impairment (HP:0001730) | 1.46632751 |
| 178 | Decreased muscle mass (HP:0003199) | 1.46506492 |
| 179 | Esophageal atresia (HP:0002032) | 1.46052461 |
| 180 | Irritability (HP:0000737) | 1.45932213 |
| 181 | Progressive neurologic deterioration (HP:0002344) | 1.45789206 |
| 182 | Abnormal biliary tract physiology (HP:0012439) | 1.45771254 |
| 183 | Bile duct proliferation (HP:0001408) | 1.45771254 |
| 184 | Septo-optic dysplasia (HP:0100842) | 1.44815713 |
| 185 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.44656005 |
| 186 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.44656005 |
| 187 | Agitation (HP:0000713) | 1.44249434 |
| 188 | Deep venous thrombosis (HP:0002625) | 1.44147524 |
| 189 | Abnormality of male internal genitalia (HP:0000022) | 1.44113622 |
| 190 | Sensory axonal neuropathy (HP:0003390) | 1.43794164 |
| 191 | Vascular tortuosity (HP:0004948) | 1.40753618 |
| 192 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.33446524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP2K3 | 7.76679873 |
| 2 | MAP3K3 | 6.60300160 |
| 3 | KIT | 5.35933947 |
| 4 | CDK19 | 5.13736898 |
| 5 | PRKD2 | 4.08612804 |
| 6 | TRIB3 | 4.04023109 |
| 7 | TAOK3 | 3.97152915 |
| 8 | TRIM28 | 3.75864614 |
| 9 | MAP4K2 | 3.58695874 |
| 10 | SGK2 | 3.03624148 |
| 11 | TNK2 | 2.72108562 |
| 12 | SGK494 | 2.52804320 |
| 13 | SGK223 | 2.52804320 |
| 14 | PRKCH | 2.51712068 |
| 15 | BCKDK | 2.29933522 |
| 16 | MATK | 2.20495252 |
| 17 | BMX | 2.19234222 |
| 18 | FES | 2.16009245 |
| 19 | SGK3 | 2.15660872 |
| 20 | GRK6 | 1.97315616 |
| 21 | PIK3CG | 1.94255595 |
| 22 | NME2 | 1.69012324 |
| 23 | MAP4K1 | 1.67399928 |
| 24 | MST4 | 1.65533206 |
| 25 | TLK1 | 1.62857430 |
| 26 | ADRBK2 | 1.60825181 |
| 27 | IRAK3 | 1.60246969 |
| 28 | IKBKB | 1.57153803 |
| 29 | TIE1 | 1.51714238 |
| 30 | TGFBR2 | 1.49024949 |
| 31 | MAP3K4 | 1.48074124 |
| 32 | ZAP70 | 1.47424214 |
| 33 | NUAK1 | 1.38837856 |
| 34 | TRPM7 | 1.34693931 |
| 35 | PTK2B | 1.33561040 |
| 36 | DAPK2 | 1.31616816 |
| 37 | BMPR2 | 1.30306295 |
| 38 | MAP2K7 | 1.28792288 |
| 39 | ZAK | 1.26029260 |
| 40 | MAP2K4 | 1.25833234 |
| 41 | MAPKAPK5 | 1.21295107 |
| 42 | LYN | 1.21267533 |
| 43 | EIF2AK1 | 1.17568139 |
| 44 | VRK2 | 1.10167518 |
| 45 | KDR | 1.10037773 |
| 46 | MAPKAPK3 | 1.09806802 |
| 47 | SYK | 1.07404091 |
| 48 | PIM2 | 1.06638574 |
| 49 | ERN1 | 0.97600365 |
| 50 | ILK | 0.93843637 |
| 51 | ITK | 0.92208829 |
| 52 | PAK2 | 0.90568487 |
| 53 | MUSK | 0.87051184 |
| 54 | ADRBK1 | 0.86472214 |
| 55 | MARK3 | 0.86213651 |
| 56 | MAP3K10 | 0.85401339 |
| 57 | FGR | 0.83104743 |
| 58 | CDK12 | 0.82949759 |
| 59 | IRAK2 | 0.82927640 |
| 60 | MAP3K11 | 0.82776515 |
| 61 | IRAK1 | 0.82668345 |
| 62 | TAOK2 | 0.81566946 |
| 63 | BLK | 0.80085186 |
| 64 | LCK | 0.79182292 |
| 65 | PRKCQ | 0.78070903 |
| 66 | DAPK1 | 0.77385159 |
| 67 | IRAK4 | 0.73026707 |
| 68 | CSK | 0.72295650 |
| 69 | MKNK1 | 0.71485578 |
| 70 | SCYL2 | 0.71079977 |
| 71 | DAPK3 | 0.69860868 |
| 72 | MAP3K9 | 0.69319776 |
| 73 | PRKCE | 0.68291659 |
| 74 | ACVR1B | 0.66244456 |
| 75 | MAP2K2 | 0.63811667 |
| 76 | BRD4 | 0.59318054 |
| 77 | MARK1 | 0.58765985 |
| 78 | RIPK4 | 0.57997017 |
| 79 | CSF1R | 0.55157018 |
| 80 | CAMKK2 | 0.54307607 |
| 81 | CASK | 0.53767160 |
| 82 | MAP3K5 | 0.52739950 |
| 83 | CDK9 | 0.52478102 |
| 84 | FER | 0.52465650 |
| 85 | MAP2K6 | 0.51033021 |
| 86 | PAK1 | 0.50548339 |
| 87 | NEK9 | 0.49405771 |
| 88 | GRK7 | 0.49241949 |
| 89 | VRK1 | 0.49165697 |
| 90 | TNIK | 0.48945569 |
| 91 | TESK2 | 0.48909499 |
| 92 | EGFR | 0.48709341 |
| 93 | GSK3A | 0.48220480 |
| 94 | PINK1 | 0.47915595 |
| 95 | FRK | 0.46534335 |
| 96 | JAK2 | 0.45428371 |
| 97 | PIM1 | 0.44790130 |
| 98 | TBK1 | 0.44459574 |
| 99 | PKN2 | 0.44300268 |
| 100 | MAP3K13 | 0.44064974 |
| 101 | TAOK1 | 0.43506953 |
| 102 | PRKCD | 0.42074534 |
| 103 | MAP2K1 | 0.40347084 |
| 104 | DYRK2 | 0.39796274 |
| 105 | NTRK2 | 0.39491401 |
| 106 | PRKG2 | 0.39455289 |
| 107 | MAPK13 | 0.38714183 |
| 108 | UHMK1 | 0.37443278 |
| 109 | EPHB2 | 0.37266592 |
| 110 | MAP3K12 | 0.36802036 |
| 111 | PRKAA2 | 0.36573662 |
| 112 | MAP3K7 | 0.36453462 |
| 113 | HIPK2 | 0.36231823 |
| 114 | SGK1 | 0.36041823 |
| 115 | PDK1 | 0.35772179 |
| 116 | MAP3K14 | 0.34833547 |
| 117 | STK16 | 0.34548255 |
| 118 | SIK1 | 0.30431789 |
| 119 | MINK1 | 0.30142023 |
| 120 | CDK5 | 0.29632149 |
| 121 | BTK | 0.29480318 |
| 122 | ABL1 | 0.27728478 |
| 123 | IGF1R | 0.27570229 |
| 124 | CHUK | 0.26018420 |
| 125 | MAPK12 | 0.25989716 |
| 126 | CDK6 | 0.25258461 |
| 127 | PRKACG | 0.24564747 |
| 128 | PRKD1 | 0.24468324 |
| 129 | WNK3 | 0.24341055 |
| 130 | MARK2 | 0.24211043 |
| 131 | TEC | 0.23292609 |
| 132 | CAMK2B | 0.22537466 |
| 133 | RPS6KB2 | 0.22232363 |
| 134 | PHKG1 | 0.19889664 |
| 135 | PHKG2 | 0.19889664 |
| 136 | CAMK2D | 0.19133938 |
| 137 | MAPK3 | 0.18593068 |
| 138 | GRK5 | 0.18443106 |
| 139 | PRKCA | 0.16251393 |
| 140 | PRKACA | 0.15779599 |
| 141 | PDPK1 | 0.15766370 |
| 142 | CAMK2A | 0.15082219 |
| 143 | FLT3 | 0.14045838 |
| 144 | RPS6KA5 | 0.13876342 |
| 145 | PKN1 | 0.13694334 |
| 146 | NTRK3 | 0.13304955 |
| 147 | RPS6KA3 | 0.12512992 |
| 148 | MYLK | 0.12502242 |
| 149 | ABL2 | 0.12449588 |
| 150 | RET | 0.12294743 |
| 151 | MTOR | 0.12192543 |
| 152 | HCK | 0.11935357 |
| 153 | MAPK4 | 0.11754809 |
| 154 | TTN | 0.11489159 |
| 155 | STK10 | 0.11389042 |
| 156 | JAK3 | 0.11281456 |
| 157 | PAK6 | 0.11078792 |
| 158 | MAPKAPK2 | 0.10669164 |
| 159 | PRKACB | 0.10660181 |
| 160 | MOS | 0.09752584 |
| 161 | IKBKE | 0.09741587 |
| 162 | ERBB3 | 0.09357481 |
| 163 | CDK11A | 0.09281820 |
| 164 | INSR | 0.09196646 |
| 165 | EPHA4 | 0.09043307 |
| 166 | TXK | 0.08985539 |
| 167 | SIK3 | 0.08874582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Selenocompound metabolism_Homo sapiens_hsa00450 | 5.13813965 |
| 2 | Asthma_Homo sapiens_hsa05310 | 4.26545334 |
| 3 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.82247722 |
| 4 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.79978407 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.62488666 |
| 6 | GnRH signaling pathway_Homo sapiens_hsa04912 | 2.40808463 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.40603665 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.32217272 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.26318686 |
| 10 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.25363683 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.14530099 |
| 12 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.10518395 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.07700822 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.05828404 |
| 15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.95846092 |
| 16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.95417004 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.89652529 |
| 18 | Nicotine addiction_Homo sapiens_hsa05033 | 1.83095439 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.80977006 |
| 20 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.80052581 |
| 21 | Olfactory transduction_Homo sapiens_hsa04740 | 1.80035179 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.70520412 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.70109649 |
| 24 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.68299766 |
| 25 | GABAergic synapse_Homo sapiens_hsa04727 | 1.65393001 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.62644788 |
| 27 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.59700112 |
| 28 | Circadian entrainment_Homo sapiens_hsa04713 | 1.59474486 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.58059617 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.57093839 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.56163674 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.52133814 |
| 33 | Morphine addiction_Homo sapiens_hsa05032 | 1.49450944 |
| 34 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.47053201 |
| 35 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.43325126 |
| 36 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.38786097 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.37029169 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.35502506 |
| 39 | Mismatch repair_Homo sapiens_hsa03430 | 1.34653619 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.33694219 |
| 41 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.32872210 |
| 42 | Taste transduction_Homo sapiens_hsa04742 | 1.28135755 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.26256884 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.22224673 |
| 45 | Salivary secretion_Homo sapiens_hsa04970 | 1.21642773 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.21391013 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.21379664 |
| 48 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.17661675 |
| 49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.17364380 |
| 50 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.16439443 |
| 51 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.15488629 |
| 52 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.14825977 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12827414 |
| 54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.11953806 |
| 55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.09665016 |
| 56 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.09482173 |
| 57 | Malaria_Homo sapiens_hsa05144 | 1.09099563 |
| 58 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.08720241 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08530218 |
| 60 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.04255500 |
| 61 | Renin secretion_Homo sapiens_hsa04924 | 1.03880863 |
| 62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03267260 |
| 63 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.00855777 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00798647 |
| 65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.99331604 |
| 66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.99052615 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.98787037 |
| 68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.98170257 |
| 69 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96630834 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95961176 |
| 71 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.95081496 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.94607505 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93631425 |
| 74 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.93474309 |
| 75 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92061058 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.91693237 |
| 77 | Legionellosis_Homo sapiens_hsa05134 | 0.91431855 |
| 78 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.89443694 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.89011227 |
| 80 | Phototransduction_Homo sapiens_hsa04744 | 0.88376056 |
| 81 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.88102325 |
| 82 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.87447267 |
| 83 | Insulin secretion_Homo sapiens_hsa04911 | 0.87042331 |
| 84 | Base excision repair_Homo sapiens_hsa03410 | 0.86849113 |
| 85 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.86135166 |
| 86 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.85782357 |
| 87 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83880090 |
| 88 | Tuberculosis_Homo sapiens_hsa05152 | 0.82565594 |
| 89 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82018165 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.81000252 |
| 91 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.79744014 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.78948639 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78198220 |
| 94 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77123143 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.76822067 |
| 96 | Long-term depression_Homo sapiens_hsa04730 | 0.76570128 |
| 97 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.76245663 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75971233 |
| 99 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75346262 |
| 100 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.75263369 |
| 101 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73807818 |
| 102 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.73285683 |
| 103 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.73145487 |
| 104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72967798 |
| 105 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.72718145 |
| 106 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.72250533 |
| 107 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.71358231 |
| 108 | Alcoholism_Homo sapiens_hsa05034 | 0.69898995 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.69307475 |
| 110 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.67950005 |
| 111 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67591810 |
| 112 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.67496771 |
| 113 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.64766266 |
| 114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64492597 |
| 115 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.64298065 |
| 116 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.64051301 |
| 117 | Pertussis_Homo sapiens_hsa05133 | 0.63645641 |
| 118 | Peroxisome_Homo sapiens_hsa04146 | 0.63025777 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62187558 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61036494 |
| 121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60992218 |
| 122 | Shigellosis_Homo sapiens_hsa05131 | 0.60409122 |
| 123 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.59999867 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57929338 |
| 125 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57785082 |
| 126 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.57642584 |
| 127 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.57390778 |
| 128 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57060818 |
| 129 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56577734 |
| 130 | Viral myocarditis_Homo sapiens_hsa05416 | 0.56561402 |
| 131 | Influenza A_Homo sapiens_hsa05164 | 0.55710117 |
| 132 | Phagosome_Homo sapiens_hsa04145 | 0.55475274 |
| 133 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55164093 |
| 134 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.55076627 |
| 135 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55013636 |
| 136 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54835686 |
| 137 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54557725 |
| 138 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54225666 |
| 139 | Gap junction_Homo sapiens_hsa04540 | 0.52637943 |
| 140 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.51570782 |
| 141 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.51331070 |
| 142 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51208062 |
| 143 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.51122640 |
| 144 | Long-term potentiation_Homo sapiens_hsa04720 | 0.49794196 |
| 145 | Mineral absorption_Homo sapiens_hsa04978 | 0.49778837 |
| 146 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48466311 |
| 147 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47385415 |
| 148 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.45653067 |
| 149 | Cocaine addiction_Homo sapiens_hsa05030 | 0.45593818 |
| 150 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.45564882 |
| 151 | RNA polymerase_Homo sapiens_hsa03020 | 0.45003983 |
| 152 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.44453851 |
| 153 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.43648367 |
| 154 | Axon guidance_Homo sapiens_hsa04360 | 0.43596524 |
| 155 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.42946919 |
| 156 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.42681541 |
| 157 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.42387981 |
| 158 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41790988 |
| 159 | Apoptosis_Homo sapiens_hsa04210 | 0.41730077 |
| 160 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41292195 |
| 161 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40919938 |
| 162 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.39572937 |
| 163 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.39088069 |
| 164 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.37072640 |
| 165 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36951542 |
| 166 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.36735431 |
| 167 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.34513084 |
| 168 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.33990920 |
| 169 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33184259 |

